|
|
Otorhinolaryngology and Irradiation
HIV protease inhibitors that block GLUT4 precipitate acute, decompensated heart failure in a mouse model of dilated cardiomyopathy.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.
Lancet
HIV protease inhibitors elicit volume-sensitive Cl- current in cardiac myocytes via mitochondrial ROS.
Journal of molecular and cellular cardiology
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients.
AIDS (London, England)
Cardiovascular disease in HIV infection.
American heart journal
Direct comparison of the acute in vivo effects of HIV protease inhibitors on peripheral glucose disposal.
Journal of acquired immune deficiency syndromes (1999)
Dyslipidemia in the era of HIV protease inhibitors.
Progress in cardiovascular diseases
HAART patients can face greater risk of developing heart disease--studies.
AIDS alert
Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.
Clinical pharmacokinetics
HIV protease inhibitors and dyslipidemia.
AIDS reviews
Protein tyrosyl phosphatases in T cell activation: implication for human immunodeficiency virus transcriptional activity.
Progress in nucleic acid research and molecular biology
Risk-benefit of HMG-CoA reductase inhibitors in the treatment of HIV protease inhibitor-related hyperlipidaemia.
Expert opinion on drug safety
Hyperlipidemia in HIV-infected children treated with protease inhibitors: relevance for cardiovascular diseases.
Journal of acquired immune deficiency syndromes (1999)
Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?
Journal of acquired immune deficiency syndromes (1999)
Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3'-azido-3'-deoxythymidine.
Cardiovascular toxicology
Symptomatic orthostasis with extended-release nifedipine and protease inhibitors.
Pharmacotherapy
[Atherosclerosis in HIV-positive patients].
Zeitschrift für Kardiologie
Thiazolidinediones could improve endothelial dysfunction and risk of premature coronary heart disease in HIV-infected patients.
Journal of cardiovascular pharmacology and therapeutics
Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.
AIDS (London, England)
Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: report of four cases and review.
Clinical cardiology
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.
Lancet
HIV protease inhibitors elicit volume-sensitive Cl- current in cardiac myocytes via mitochondrial ROS.
Journal of molecular and cellular cardiology
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients.
AIDS (London, England)
Cardiovascular disease in HIV infection.
American heart journal
Direct comparison of the acute in vivo effects of HIV protease inhibitors on peripheral glucose disposal.
Journal of acquired immune deficiency syndromes (1999)
Dyslipidemia in the era of HIV protease inhibitors.
Progress in cardiovascular diseases
HAART patients can face greater risk of developing heart disease--studies.
AIDS alert
Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.
Clinical pharmacokinetics
HIV protease inhibitors and dyslipidemia.
AIDS reviews
Protein tyrosyl phosphatases in T cell activation: implication for human immunodeficiency virus transcriptional activity.
Progress in nucleic acid research and molecular biology
Risk-benefit of HMG-CoA reductase inhibitors in the treatment of HIV protease inhibitor-related hyperlipidaemia.
Expert opinion on drug safety
Hyperlipidemia in HIV-infected children treated with protease inhibitors: relevance for cardiovascular diseases.
Journal of acquired immune deficiency syndromes (1999)
Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?
Journal of acquired immune deficiency syndromes (1999)
Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3'-azido-3'-deoxythymidine.
Cardiovascular toxicology
Symptomatic orthostasis with extended-release nifedipine and protease inhibitors.
Pharmacotherapy
[Atherosclerosis in HIV-positive patients].
Zeitschrift für Kardiologie
Thiazolidinediones could improve endothelial dysfunction and risk of premature coronary heart disease in HIV-infected patients.
Journal of cardiovascular pharmacology and therapeutics
Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.
AIDS (London, England)
Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: report of four cases and review.
Clinical cardiology
Get breaking news about nutritional cures, dangerous chemicals, superfoods and more.
Subscribe to the FREE Natural News email newsletter. Your privacy is protected.
See more studies on Otorhinolaryngology and...
How is this determined?
The order of these related concepts is determined by a statistical analysis of the scientific literature. Highest-frequency concepts appear first.
|
Otitis 109 Tumor 107 cancer 87 blood 80 sinusitis 73 pharynx 72 Hearing Loss 70 otitis media 66 Inflammatory 64 larynx 62 pain 55 radiation 54 skin 52 lead 42 sleep 36 radiotherapy 36 Squamous cell carcinoma 35 antibiotics 32 thyroid 31 Urology 29 Magnetic resonance 28 smoking 28 Vertigo 27 Allergy 26 Tonsillitis 26 Allergic Rhinitis 25 |
Mouth 24 Tongue 24 CO2 23 Tinnitus 23 Irradiation 22 tonsils 21 Infectious 21 Antimicrobial 20 Neurology 19 cartilage 19 Deafness 15 Asthma 15 bones 14 Tracheostomy 14 Dizziness 14 Tuberculosis 14 Dysphagia 13 AIDS 13 cough 12 lymphoma 12 Amoxicillin 11 Sarcoma 11 trachea 10 Laryngitis 10 Meningitis 10 |
